Insmed, Inc. (INSM)
109.14
-6.48
(-5.60%)
USD |
NASDAQ |
May 15, 16:00
109.44
+0.30
(+0.27%)
After-Hours: 20:00
Insmed EPS Diluted (Quarterly) : -0.7591 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | -3.251 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| PTC Therapeutics, Inc. | -0.034 |
| Revolution Medicines, Inc. | -2.291 |
| United Therapeutics Corp. | 5.824 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -163.56M |
| Revenue (Quarterly) | 305.96M |
| Total Expenses (Quarterly) | 469.53M |
| Enterprise Value | 23.18B |
| Gross Profit Margin (Quarterly) | 83.82% |
| Profit Margin (Quarterly) | -53.46% |
| Earnings Yield | -5.26% |
| Normalized Earnings Yield | -4.675 |